DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...

June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it was unaware the Dexcom (DXCM.O), opens new tab glucose sensors it bought from licensed distributors had been ‌slated for destruction, after ...

Add Yahoo as a preferred source to see more of our stories on Google. June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it was unaware the Dexcom glucose ‌sensors it bought from licensed ...

When the Dexcom G7 works, it works brilliantly, one Dexcom caregiver said in a Facebook group called Dexcom G7 Issues and Complaints. Unfortunately, the same group member, whose nickname in the group ...

Add Yahoo as a preferred source to see more of our stories on Google. Dexcom received FDA clearance for a 15-day version of its G7 continuous glucose monitor. (Courtesy of Dexcom) This story was ...

Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...

Smartwatches may transform blood sugar tracking, but today’s advances depend on CGMs, AI, and regulated health tech ...

Every day there are new posts in a Facebook group — 89.5 thousand members strong — dedicated to Dexcom G7 issues and complaints. From inaccurate CGM readings and sensor failures to frustrating ...

Dexcom is transforming its Stelo CGM into a whole-family wellness device, securing FDA clearance for pediatric use and debuting new AI tools.

AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...

Dexcom received FDA clearance for its first over-the-counter continuous glucose monitor, called Stelo. The device is intended for people with Type 2 diabetes who do not take insulin. · MedTech Dive · ...